New injection targets chronic back pain in early trial
Symptom relief
Not yet recruiting
This early-stage trial tests a single injection of ITX24-01 in 32 adults with severe chronic facet joint pain in the neck or lower back. The main goal is to see if the drug is safe and tolerable compared to a placebo. Researchers will also look for early signs of pain relief.
Phase: PHASE1 • Sponsor: Interventional AnalgesiX Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC